The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
暂无分享,去创建一个
[1] Otto Warburn,et al. THE METABOLISM OF TUMORS , 1931 .
[2] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[3] R. Middleton. Surgery for metastatic renal cell carcinoma. , 1967, The Journal of urology.
[4] H. Rubin. pH AND POPULATION DENSITY IN THE REGULATION OF ANIMAL CELL MULTIPLICATION , 1971, The Journal of cell biology.
[5] J. Montie,et al. The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. , 1977, The Journal of urology.
[6] J S Fowler,et al. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] G. di Chiro,et al. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. , 1987, Radiology.
[8] B. Reid,et al. Progression to cancer in Barrett's esophagus is associated with genomic instability. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[9] L. Loeb,et al. Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.
[10] J. Griffiths. Are cancer cells acidic? , 1991, British Journal of Cancer.
[11] R. Gatenby,et al. Population ecology issues in tumor growth. , 1991, Cancer research.
[12] G van Kaick,et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] S. V. Sotirchos,et al. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH , 1992, Journal of cellular physiology.
[14] J. Folkman,et al. The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.
[15] A. Velázquez,et al. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] E. Hoffman,et al. The role of positron emission tomography in oncology and other whole-body applications. , 1992, Seminars in nuclear medicine.
[17] P. Choyke,et al. Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy. , 1993, The Journal of urology.
[18] R K Jain,et al. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. , 1994, Cancer research.
[19] Bonnie F. Sloane,et al. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. , 1994, Cancer research.
[20] V. Lowe,et al. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. , 1994, Radiology.
[21] R. Gillies,et al. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. , 1994, The American journal of physiology.
[22] K. Jeong,et al. Metabolic consequences of a reversed pH gradient in rat tumors. , 1994, Cancer research.
[23] S. Dairkee,et al. Selective cell culture of primary breast carcinoma. , 1995, Cancer research.
[24] R. Gatenby,et al. The potential role of transformation-induced metabolic changes in tumor-host interaction. , 1995, Cancer research.
[25] R. Gatenby,et al. Models of tumor-host interaction as competing populations: implications for tumor biology and treatment. , 1995, Journal of theoretical biology.
[26] E. T. Gawlinski,et al. A reaction-diffusion model of cancer invasion. , 1996, Cancer research.
[27] R. Gatenby,et al. Application of competition theory to tumour growth: implications for tumour biology and treatment. , 1996, European journal of cancer.
[28] Altered glucose metabolism and the invasive tumor phenotype. , 1996, International journal of oncology.
[29] D. Birnbaum,et al. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. , 1997, Cancer research.
[30] M. Gleave,et al. Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. , 1998, The New England journal of medicine.
[31] T. Ohtsubo,et al. Acidic environment causes apoptosis by increasing caspase activity , 1999, British Journal of Cancer.
[32] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[33] C. Paraskeva,et al. An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis , 1999, Oncogene.
[34] A. Schäffer,et al. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. , 2000, Cancer research.
[35] M J Bissell,et al. The influence of the microenvironment on the malignant phenotype. , 2000, Molecular medicine today.
[36] J. Gray,et al. Genome changes and gene expression in human solid tumors. , 2000, Carcinogenesis.
[37] E. T. Gawlinski,et al. Mathematical models of tumour invasion mediated by transformation-induced alteration of microenvironmental pH. , 2001, Novartis Foundation symposium.
[38] D. Chadwick,et al. The Tumour Microenvironment: Causes and Consequences of Hypoxia and Acidity , 2001 .
[39] J. Abbruzzese,et al. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells , 2001, Oncogene.
[40] R. Sylvester,et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial , 2001, The Lancet.
[41] N. Munshi,et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. , 2001, The New England journal of medicine.
[42] N. Nishiumi,et al. 18F-FDG PET detection of colonic adenomas. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] E. T. Gawlinski,et al. A Cellular Automaton Model of Early Tumor Growth and Invasion: The Effects of Native Tissue Vascularity and Increased Anaerobic Tumor Metabolism , 2001 .
[44] A. Lardner. The effects of extracellular pH on immune function , 2001, Journal of leukocyte biology.
[45] H. Rubin. Selected cell and selective microenvironment in neoplastic development. , 2001, Cancer research.
[46] L. Klotz. Back to nephrectomy for patients with metastatic renal cancer , 2001, The Lancet.
[47] S. Bonhoeffer,et al. Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.
[48] Robert A. Gatenby,et al. Modelling a new angle on understanding cancer , 2002, Nature.
[49] J. Perpich. DNA committee is model for bioterrorism debate , 2002, Nature.
[50] E. T. Gawlinski,et al. The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomy. , 2002, Cancer research.
[51] D. Fraker,et al. Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model. , 2002, Surgery.
[52] P. Maini,et al. Mathematical oncology: Cancer summed up , 2003, Nature.